Objectives: The aim of this study was to investigate the potential effects of Sargassum oligocystum extract on the pentylenetetrazole (PTZ) seizure and the contribution of antioxidant capacity of this alga to its antiepileptic effect. Methods: A dose of 100 mg/kg PTZ was used to induce the seizure in the male albino mice. Extract of Sargassum oligocystum in four doses (100, 200, 400 and 600 mg/kg), diazepam (5 mg/kg) and the vehicle were used 30 min before the injection of PTZ (n = 8). The onsets of clonic and tonic-clonic seizures, as well as the latency of death of animals, were recorded and the total antioxidant capacity (TAC), Superoxide dismutase (SOD) activity and catalase level were measured. Data were analyzed using one-way ANOVA or Kruskal-Wallis tests. Results: Sargassum oligocystum extract at the doses of 400 and 600 mg/kg significantly increased the latency of clonic and tonic-clonic seizures. Also, at the doses of 100, 200 and 400 mg/kg significantly increased the TAC. Moreover, Sargassum oligocystum at the doses of 200 and 400 mg/kg increased the SOD activity and at the doses of 400 and 600 mg/kg increased the catalase level in neural cells compared with the vehicle-treated group. Conclusion: Sargassum oligocystum extract inhibited PTZ-induced seizure. Attenuation of oxidative stress may partly be responsible for the anticonvulsant effects of this alga in the PTZ-induced seizures. Therefore, marine algae, especially Sargassum oligocystum, may be a valuable target to discover new antiepileptic drugs.
Introduction
Epilepsy is one of the most prevalent neurological disorder around the world.1 It has been estimated that 5.8 per 1000 population in developed countries and about 12.8 per 1000 in lower income countries suffer from this disorder.2 Pharmacotherapy is the primary method for controlling epileptic seizure. However, about 30% of patients suffer from refractory epilepsy or are unable to tolerate the adverse effects of antiepileptic drugs.3,4 Thus, it is of great importance to find new drugs with increased safety and efficacy profile.
The exact pathophysiology of epileptic seizure needs to be fully elucidated, though the imbalance between the excitatory and inhibitory neurotransmission in the central nervous system (CNS) may play important roles in this disorder.5,6 Furthermore, increased oxidative stress have a great contribution to the pathophysiology of epilepsy.7 Several animal models including the amygdala kindling,8 kainic acid,9 PTZ kindling,10 and acute PTZ-induced seizures11 have confirmed the involvement of enhanced oxidative stress in experimental epilepsy. Successful administration of the antioxidants in various models of epilepsy may be another proof for the association of oxidative stress with epileptic seizure. 12, 13 Currently, phytomedicines are widely used for the management of epilepsy in many parts of the world14 and there is growing interest in using natural products as an alternative source for antiepileptic drugs. 15, 16 Marine algae have several biological activities, nutritional benefits, and medicinal potential17 with confirmed antioxidant18 and anti-inflammatory19 activities. Thus, phytomedicine like marine algae may be favorite targets for developing new antiepileptic drugs. 20 Sargassaceae family is brown algae which are widely distributed in the tropical and subtropical oceans in the world.21 Sargassum oligocystum (S. oligocyctum) is a member of Sargassaceae family that is widely spread over the coastal waters of Persian Gulf. 22 There are many in vitro and in vivo studies about the antioxidant capacity of Sargassum species in the peripheral tissues.23,24 With regards to the antioxidant activity of S. oligocyctum25 and the role of oxidative stress in the pathophysiology of the epileptic seizure, the study was designed to assess the potential effects of S. oligocyctum extract on the pentylenetetrazole (PTZ) seizure and the contribution of antioxidant activity of this alga to its antiepileptic effect.
Materials and methods

Alga materials and preparation of hydroalcoholic extract
We collected S. oligocyctum from the coastal waters of Bushehr (southwest of Iran) in May 2016. They were thoroughly washed with double distilled water to remove impurities, dried in the ambient temperature and finally ground into fine powder. Then; it was soaked in ethanol (70%) at a ratio of 1:10. The mixture was homogenized for 72 h on a shaker. The supernatant was filtered using Whatman paper No. 1 and centrifuged at 4000 rpm, 4 C for 10 min. The solvent was separated using the rotary evaporator, and the extract was kept in the refrigerator (4 C) until use.
Study design
Male albino Swiss strain of mice was obtained from Razi Institute (Tehran, Iran). We kept animals in the Plexiglas cages (5 animals per each cage) on a regular dark/light cycles (12 h/12 h), controlled temperature (22 AE2 C) and free access to food and water. Forty-eight mice were randomly allocated to the 6 separate groups (n = 8). We used S. oligocyctum extract in four different doses (100, 200, 400and 600 mg/kg), diazepam (5 mg/kg as a standard antiepileptic drug that is used in PTZ model), and the vehicle (normal saline) 30 min before the PTZ injection. The experiment was approved by the local Animal Ethics Committee, which follows the European Communities Council to minimize the number and suffering of animals.
Seizures induced by PTZ
PTZ at a dose of 100 mg/kg was used for the induction of clonic and tonic-clonic seizures in mice. After injection of PTZ, animals were moved into separate cages and monitored for 30 min. The clonic seizure was defined as an over 3 second's clonus of the animal body which was accompanied by the loss of righting reflex. 26 Generalized clonus of animal body with the extension of both forelimbs and hind limb was defined as the generalized tonicclonic seizure. We recorded the latency of the clonic and generalized tonic-clonic seizures. Finally, the latency of death of animals after injection of PTZ and the number of animals protected from PTZ-induced seizure and death were recorded.
Brain tissue homogenate preparation and the measurement of anti-oxidative parameters
Thirty minutes after the injection of PTZ, the mice were sacrificed by neck dislocation. Then, the whole brain was removed, washed and stored in the phosphate buffer saline (PBS) (pH = 7.4) at À20
C. On the day of the experiment, the whole brain was washed again, twice with cold PBS. The tissues were homogenized using tris aminomethane buffer (0.1 M, pH = 7.4), triton X-100 (0.5%) and mercaptoethanol (ME) (5 mM) at 4 C. The homogenate was centrifuged at 14000g, 4 C for 5 min and the supernatant was used to measure the antioxidant capacity and enzymes. The total antioxidant capacity (TAC), superoxide dismutase (SOD) activity and catalase level were measured using commercial kits (Biovision, USA).
Statistical analysis
The Kolmogorov-Smirnov test was used to check the normal distribution of variables. We reported median and inter quartile range 25 (IQR25) for non-normal distributed variables and the mean AE standard error of the mean (SEM) for other variables. We used Kruskal-Wallis test followed by the Dunn's test to analyze the clonic, tonic-clonic seizure and latency for death, mainly because of deviation from the normal distribution of these variables. Furthermore, we used one-way ANOVA followed by an LSD test for pairwise comparison of TAC, SOD and catalase data. We considered the p-value of lower than 0.05 as the significant level. All the analyses were carried out with SPSS software version 23.
Results
Effects of S. oligocystom extract on the onset of PTZ-induced clonic and tonic-clonic seizures
The Kruskal-Wallis analysis showed a significant difference between various treatment groups (X 2 (5) = 28.47, p = 0.000) ( Table 1) . Diazepam increased the onset of PTZ-induced clonic seizure compared with the vehicle-treated group (Table 1) . Moreover, S. oligocyctum extract at the doses of 400 and 600 mg/kg had a higher latency of the clonic seizure compared with the vehicle-treated group (Table 1) . However, S. oligocyctum (100 and 200 mg/kg) had no effect on the onset of clonic seizure in mice (Table 1 ). Our study showed that 37.5% of animals treated with diazepam and 12.5% treated with S. oligocyctum (600 mg/kg) were protected from PTZ-induced clonic seizure. Other treatments including S. oligocyctum (100, 200 and 400 mg/kg), and the vehicle did not protect animals against PTZ-induced clonic seizure. Diazepam completely protected animals against PTZ-induced tonic-clonic seizure. Moreover, 25% of animals treated with S. oligocyctum (400 mg/kg) and 12.5% treated with S. oligocyctum (600 and 100 mg/kg) did not experience the tonic-clonic seizure. Furthermore, the latency of tonic-clonic seizure was significantly different between various treatment groups (X 2 (4) = 17.29, p = 0.002) ( Table 2) . Post HOC analysis showed that S. oligocyctum (400 and 600 mg/kg) increased the latency of the tonic-clonic seizure induced by PTZ compared with the vehicle-treated group (Table 2) . However, S. oligocyctum (100 and 200 mg/kg) had no effect on the tonic-clonic seizure compared with the vehicletreated group (Table 2) .
Effects of S. oligocystom extract on the PTZ-induced mortality in mice
All the animals treated with diazepam, 50% of the animals treated with S. oligocyctum (400 and 600 mg/kg), 37.5% of the animals treated with S. oligocyctum (200 mg/kg) and 12.5% of the animals treated with S. oligocyctum (100 mg/kg) were protected against PTZ-induced mortality. Moreover, the latency of death among animals treated with various treatments was significantly different (X 2 (4) = 17.09, p = 0.002). Post HOC analysis showed that S. oligocyctum at the doses of 200, 400 and 600 mg/kg had a higher latency for death after challenging with PTZ (Table 3) . However, S. Oligocyctum at the dose of 100 mg/kg had no effect on the latency for death (Table 3) . 
Effects of S. oligocyctum on the TAC and antioxidant enzymes
Our study showed that the TAC content of the neural cells was significantly different among the treatment groups (F (4) = 8.94, p = 0.000). S. oligocyctum at the doses of 100 mg/kg (0.000), 200 mg/kg (0.000) and 400 mg/kg (0.000) significantly increased the TAC content of neural cells compared with the vehicle-treated group (Fig. 1) . However, S. oligocyctum (600 mg/kg) had no effect on the TAC level of neural cells (Fig. 1) .
Furthermore, a significant difference was observed in the neural SOD activity among treatment groups (F (4) = 7.36, p = 0.000). Post HOC analysis showed that S. oligocyctum at the doses of 200 and 400 mg/kg had significantly higher SOD activity compared with the vehicle-treated group (p = 0.001 and p = 0.000, respectively) (Fig. 2) . However, S. oligocyctum at the doses of 100 and 600 mg/ kg had no effect on the SOD activity in the neural cells (p = 0.071 and p = 0.316, respectively) (Fig. 2) .
The catalase level of neural cells was significantly different between various treatment groups (F (4) = 3.28, p = 0.024). S. oligocyctum at the doses of 400 and 600 mg/kg significantly increased the catalase level of neural cells compared with the vehicle-treated group (p = 0.034 and 0.021, respectively) (Fig. 3) . However, S. oligocyctum at the doses of 100 and 200 mg/kg had no effect on the catalase level compared with the vehicle-treated group (p = 0.369 and p = 0.121, respectively) (Fig. 3) .
Discussion
S. oligocyctum is a macroalga that is widely distributed in the coastal area of the Persian Gulf. Previous reports have shown antibacterial and anticancer effects of this marine alga.22,27 Our study also showed that S. oligocyctum extract can attenuate PTZinduced seizure in mice. There is very limited information about the antiepileptic effects of marine algae and a few reports about the anticonvulsant effects of sargassaceae family algae. However, fucosterol, a steroid derived from S. fusiforme, possessed anticonvulsant effects against electroshock seizures.28 Therefore, the sargassaceae family may be an important potential target for developing new antiepileptic drugs. In contrast, ethanol and chloroform extracts of Adina tetrastromatica, a brown macroalga, had no effect on the latency of PTZ-induced clonic seizure. 29 Numerous reports have shown the role of oxidative stress in the development of various disorders, including cancer, neurodegenerative disorders, atherosclerosis and epilepsy.7,30 Moreover, oxidative stress induced damage may be involved in the pathophysiological changes, following acute neurological insults like seizures.8,31 Animal and human studies have shown that oxidative stress markers have increased in the epileptic subjects. 32-36 Epileptogenesis in the brain impair the oxidative stress balance by reducing the antioxidant defense and increasing free radicals. 37 The enhanced oxidative stress in the brain may be correlated with decreased amount of inhibitory neurotransmitters like GABA and the initiation of convulsion in the cerebral cortex of animals.38 Furthermore, increased activity of catalase in the hippocampus has protected animals against epileptic seizure.39 Our study showed that S. oligocyctum extract enhanced antioxidant content of the animal brains when challenged with high doses of PTZ. However, only the catalase activity was matched with the anticonvulsant effects of S. oligocyctum. In accord with our study, Cárdenas-Rodríguez et al. showed that tilia, a medicinal plant, inhibited PTZ-induced seizure mainly by modulating oxidative stress in the animal brains. 40 The results of our study showed that decreasing oxidative stress by the S. oligocyctum extract may attenuate PTZ-induced seizure, but may not be able to completely block it. There are many reports about the anticonvulsant activity of medicinal plants with antioxidant effects. [41] [42] [43] In contrast, there is some inconsistency about the anticonvulsant effects of antioxidant agents.44 Trolox, a vitamin E analog, increased the latency of clonic seizure in pilocarpine and ferrous chloride39 but had no effect in the PTZ, maximal electroshock and kainic acid models.45,46 Accordingly, the attenuation of oxidative stress may be partly responsible for the inhibition of PTZ-induced seizures by the S. oligocyctum extract.
PTZ is a convulsant agents that acts via the blockade of GABAA receptor.47,48 Moreover, PTZ induced seizures are accompanied with decreased indigenous antioxidants and increased oxidative stress parameters in the mouse cerebral cortex. 49 In this regard, it has been shown that a single dose of PTZ altered GABA A receptor density and function48 and whole brain free radicals,50 reduced total SOD activity and a-tocopherol content in rat brain.51
Therefore, the convulsant effects of PTZ may contribute to the GABAA and oxidative stress modulation in the animal models of epilepsy. Our study showed that S. oligocyctum extract diminished PTZ-induced seizure and increased antioxidant capacity in the mouse brain. It is probable to assume that this alga may modulate GABA A and brain antioxidant capacity to inhibit PTZ-induced seizure in the mice. Although, the attenuating of oxidative stress may mediate, at least in part, the anticonvulsant effects of S. oligocyctum extract, there are other possibilities about the mechanism of action of this alga.
In this study, the hydroalcoholic extract of S. oligocyctum was used and the active compounds that are responsible for the anticonvulsant effects of the algae are not known. Tannins, saponins, alkaloids, sterols, flavonoids and triterpenes are the most abundant compounds in the S. oligocyctum (Table 4) . 25, 52 Among these compounds, flavonoids and sterols are substances with intense antioxidant activity.28,53 Thus, these substances may be the most important compounds responsible for the anticonvulsant effects of S. oligocyctum. Flavonoids are also structurally similar to benzodiazepine and produce an antiepileptic effect, possibly by modulation of GABA A receptors. 54 In this regard, it has been shown that allosteric modulation of benzodiazepine site of GABA A receptors may be responsible for some of central effects of herbal flavonoids. 55 It is noteworthy that the interaction of flavonoids with GABA receptor and its relevance to the epilepsy management should be confirmed in the future studies. Furthermore, fucosterol, a sterol, inhibited seizures produced by maximal electroshock in animals.28 Currently, it is not possible to show that the modulation of oxidative stress and the direct effect of compounds like flavonoids or sterols may be responsible for the anticonvulsant effects of S. oligocyctum. However, it can be proposed that the anticonvulsant effect of S. oligocyctum may be the sum of oxidative stress modulation and direct effects of active compounds of this alga. Further research may be warranted to clarify the exact mechanisms responsible for the anticonvulsant activity of S. oligocyctum.
The main limitation of this study was using the hydroalcoholic extract of S. oligocyctum. However, this extract was used to screen for potential anticonvulsant effects of this alga. It is suggested to use specific fractions and components of this alga in different animal models in the future studies. Furthermore, it is necessary to clarify the exact mechanism(s) responsible for the anticonvulsant effect of this alga.
Conclusion
S. oligocyctum extract inhibited PTZ-induced seizure and enhanced TAC, SOD and catalase levels in the mouse brain. The attenuation of oxidative stress may be, at least partly, responsible for the anticonvulsant effects of S. oligocyctum in the PTZ-induced seizures. Therefore, our study suggests that marine algae especially, S. oligocyctum may be a potential target to discover new antiepileptic drugs. Although, some studies did not show any adverse effect after using sargassum extracts, it is important to determine detailed profile of side effects of this alga before using in human studies.
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